Neudle.com: antiviral agents

Differential
(Click to cross reference)

abscess, intracerebral

abscess, intracerebral, multiple

abscess, intracerebral, tuberculous

abulia

acetylcholine receptor antibody

acquired immunodeficiency syndrome

acquired immunodeficiency syndrome defining illness

acquired immunodeficiency syndrome dementia complex

acquired immunodeficiency syndrome myelopathy

acquired immunodeficiency syndrome, heralded by neurologic invol

acquired immunodeficiency syndrome, infants and children

activities of daily living

acute disseminated encephalomyelitis

acute necrotizing encephalitis

acyclovir

adalimumab

addiction, heroin-neurologic complications with

adenine arabinoside

advances in neurology

adverse drug reaction

altered states of consciousness

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, differential diagnosis

amyotrophic lateral sclerosis, misdiagnosis

amyotrophic lateral sclerosis-like syndrome

aneurysm, intracranial

angiitis

angiography, cerebral

ankle clonous

anorexia

anosmia

anterior tibial muscle weakness

anti DNA agent

antiarrhythmic drugs

antibiotics

antibiotics, neurologic complications with

anticholinergic drugs

anticholinergic drugs, side effects of

anticonvulsants

anticonvulsants, untoward effects of

arthropathy, neuropathic

aspartate aminotransferase

attention deficit disorder with hyperactivity

bacterial infection, CNS

basal cell carcinoma

basal ganglia

basal ganglia, lesion of

basal ganglia, lesion, bilateral

basilar artery stenosis

behavior, combative

behavioral disorder

BENEFIT study

beta adrenergic blocker

blacks

bladder dysfunction

blood brain barrier

bone marrow transplantation

brain biopsy, indication

brain biopsy, stereotaxic

calcification, intracranial

CAT scan, angiography

CAT scan, chest

CAT scan, contrast enhanced

CAT scan, contrast enhanced, delayed

CAT scan, contrast enhanced, subepend.

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, false negative

CAT scan, ring sign

cataracts, congenital

cauda equina

cauda equina, enhancement

cauda equina, lesion of

CD19-directed chimeric antigen receptor T-cell therapy

CD4 counts

CD8 encephalitis

central nervous system, infection of

cerebellar atrophy, secondary

cerebellar degeneration

cerebrospinal fluid, abnormal

cerebrospinal fluid, culture of

cerebrospinal fluid, culture of, viral

cerebrospinal fluid, cytology

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, gammaglobulin of

cerebrospinal fluid, oligoclonal IgG in

cerebrospinal fluid, red cells in

cerebrospinal fluid, xanthochromia of

cerebrovascular accident

cerebrovascular accident, clinical diagnosis

cerebrovascular accident, delayed onset

cerebrovascular accident, differential diagnosis of

cerebrovascular accident, mimics

Charcot joint

chemotherapy, CNS treatment and complications with

choroid plexus, enhancement

chromosome 4

chronic fatigue syndrome

Churg-Strauss syndrome

ciprofloxacin

Clinical Pathologic Conference(C.P.C.)

concentration, impaired

confusion

confusional state, acute

congenital infection, CNS

congenital infection, viral

conjunctival injection

contrast agents, neurotoxicity of

controversies in neurology

cop 1

coronavirus

corpus callosum, lesion of

cranial nerve enhancement

cranial nerve palsies

C-reactive protein, elevated

creatine phosphokinase(CPK)elevated

cryptococcal meningitis

cryptococcoma, cerebral

cytokine release syndrome

cytokines

cytomegalic inclusion disease

cytomegalovirus infection

cytomegalovirus infection, congenital

cytosine arabinoside

daclizumab

deep gray nuclei

degenerative diseases of CNS

delay in diagnosis

dementia

dementia, rapidly progressive

dementia, subcortical

dementia, treatment of

demyelinating disease

deprenyl

depression

depression, psychotic

developmental disability

developmental evaluation

developmental retardation

differential diagnosis

difficulty climbing stairs

difficulty going down stairs

diffuse infiltrative lymphocytosis syndrome

dilantin

disability rating scale, neurological

disability, neurological

disorientation

distal muscle weakness

dizziness

drowsiness

drug abuse

drug induced neurologic disorders

drug induced neurologic disorders in children

electroencephalogram, abnormalities of

electroencephalogram, diffuse slowing

electroencephalogram, periodic complexes

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, clinical picture and treatment of

encephalitis, diagnosis of

encephalitis, etiology

encephalitis, focal

encephalitis, human immunodeficiency virus type 1

encephalitis, Rasmussen's

encephalitis, recurrent

encephalitis, unknown etiology

encephalitis, viral

encephalitis, viral-causes of

encephalomyelitis

encephalomyelitis, postinfectious

encephalopathy

encephalopathy, acute

ependymitis

epidemiology of neurology

evidence-based research

executive dysfunction

facial nerve palsy, causes of

facial nerve palsy, prognosis of

facial nerve palsy, surgical treatment

facial nerve palsy, treatment of

facial nerve, lesion of

finger nose finger test

frontal lobe, pathologic signs of

fundus, abnormality of

fungal infection

fungal infection, CNS

gadolinium

gait disorder

gait, apraxic

gammaglobulin therapy, intravenous

genetic neurologic disorders

glioblastoma multiforme(astrocytoma Gr.III)

glucose tolerance test, abnormal

gram positive rod

granule cell

grasp reflex

Guillain Barre syndrome

H1N1 influenza

hallucination

hallucination, auditory

hallucination, olfactory

hallucination, visual

headache

headache, drug induced

headache, frontal

headache, progressive

headache, severe

hearing loss

hematuria, microscopic

heralding manifestation

herniation syndromes, intracranial

herpes encephalitis

herpes labialis

herpes simplex encephalitis

herpes simplex encephalitis, atypical

herpes simplex encephalitis, diagnosis of

herpes simplex encephalitis, differential diagnosis of

herpes simplex encephalitis, infancy and childhood

herpes simplex encephalitis, prognosis of

herpes simplex encephalitis, recurrent

herpes simplex encephalitis, treatment of

herpes simplex myelitis

herpes simplex virus

herpes simplex virus infection, immunosuppressed patient

herpes simplex virus infection, newborn

herpes simplex virus, human nervous system and

herpes simplex virus, localization of

herpes simplex virus, malignancy with

herpes simplex virus, pathogenesis of

herpes simplex virus, pathology of

herpes simplex, neurocutaneous lesions in

herpes virus

herpes virus infection

herpes zoster

herpes zoster, disseminated

herpes zoster, myelitis

herpes zoster, ophthalmicus

highly active antiretroviral therapy

hip flexor weakness

hippocampal atrophy

hippocampus

hippocampus, hyperintense

HIV CSF viral escape syndrome

HIV-associated neurocognitive disorder

human immunodeficiency virus type 1

human immunodeficiency virus type 1, acute infection

human immunodeficiency virus type 1, asymptomatic

human immunodeficiency virus type 1, false positive

human immunodeficiency virus type 1, infants and children

human immunodeficiency virus type 1, pathogenesis

human immunodeficiency virus type 1, prophylaxis

human immunodeficiency virus type 1, testing

human immunodeficiency virus type 2

human papilloma virus

human T-lymphotropic virus type I(HTLV-I)

hydrocephalus

hydrocephalus, exvacuo

iatrogenic neurologic disorders

ibuprofen

idiopathic thrombocytopenic purpura

imbalance

imbalance, postural

immune effector cell-associated neurotoxicity syndrome

immune reconstitution inflammatory syndrome

immune reconstitution inflammatory syndrome, paradoxical

immune reconstitution inflammatory syndrome, unmasked

immune-related adverse events

immunocompetent

immunodeficiency

immunofluorescence

immunofluorescent exam of CSF cells

immunohistochemistry

immunomodulation

immunosuppression

immunosuppressive agents

immunotherapy

impulsivity

inappropriate antidiuretic(A.D.H.)hormone

inattention

inclusion bodies

inclusion bodies, eosinophilic intranuclear

inclusion bodies, intranuclear

indinavir

infection

infectious mononucleosis

infectious mononucleosis, neurologic findings with

infliximab

influenza

influenza A virus

influenza immunization

inosiplex

insular cortex

intellectual deficit

intellectual deterioration

interferon

interferon alpha

interferon antibodies

interferon, intrathecal

interferon, intraventricular

intestinal obstruction

intracranial pressure, increased

intrathecal chemotherapy

intrauterine

intrauterine infection

intrauterine infection, viral

intrauterine infection, viral of CNS

intraventricular chemotherapy

iododeoxyuridine

Jakob-Creutzfeldt disease

leg weakness, bilateral

leg weakness, unilateral

lethargy

leukemia

leukemia, neurologic findings assoc.with

level of consciousness, decreased

liver function enzymes

lumbar puncture

lumbar puncture, complications of

lumbar puncture, indications for

lumbosacral radiculopathy

lymphadenopathy

lymphoma

lymphoma involving CNS

lymphoma, plasmablastic

lymphoma, primary of CNS

lymphoma, systemic

lymphopenia

lysosomal storage disease

malformation, CNS, congenital

medication withdrawal

memory, defect of recent

memory, impairment of

meningeal enhancement

meningitis, carcinomatous

meningitis, leukemic

meningitis, Mollaret's

meningitis, recurrent

meningitis, spinal fluid smear and culture-negative

meningitis, treatment of

meningoencephalitis

menses

menses, irregular

mental status, abnormal

middle cerebellar peduncle

middle cerebellar peduncle, lesion

middle cerebral artery territory infarction

middle cerebral artery, stenosis of

migraine

migraine, seizures in

mimics

misdiagnosis

mitochondrial disease

molecular genetics

monoamines

monoamines, brain

monoclonal antibodies

mononeuropathy multiplex

mortality

motor neuron disease

movement disorder

movement disorder, extrapyramidal

MRI, CAT scan compared to

MRI, contrast enhanced

MRI, contrast enhanced, subependymal

MRI, demyelinating disease

MRI, diffusion tensor

MRI, diffusion weighted

MRI, disappearing lesion on

MRI, false negative

MRI, FLAIR

MRI, high signal intensity of basal ganglia

MRI, hypointense signal foci on

MRI, indications for

MRI, magnetization transfer sequence

MRI, spinal cord, increased intramedullary cord signal

MRI, spine

MRI, sulcal hyperintensity

MRI, volumetry

MRS

multinucleated giant cell

multiple sclerosis

multiple sclerosis, benign form of

multiple sclerosis, children

multiple sclerosis, chronic progressive

multiple sclerosis, clinical patterns

multiple sclerosis, conversion to clinically definite

multiple sclerosis, cost of

multiple sclerosis, diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, early onset

multiple sclerosis, monosymptomatic

multiple sclerosis, pathogenesis

multiple sclerosis, prognosis

multiple sclerosis, relapsing

multiple sclerosis, secondary progressive

multiple sclerosis, treatment of

multiple sclerosis, treatment of, first attack

multiple sclerosis, worsening

muscle atrophy, progressive

muscle biopsy

muscle pain

muscle strength, testing

muscle tenderness

muscle wasting, diffuse

muscle weakness

muscle weakness, proximal

myasthenia gravis

myasthenia gravis, drug induced

myasthenia gravis, unmasked

myasthenic syndrome

mycobacterium avium-intracellulare

mycoplasma pneumoniae

myelitis

myelitis, transverse

myelitis, transverse, recurrent

myelopathy

myelopathy, ascending

myopathy, drug-induced

myopathy, mitochondrial

myopathy, necrotizing

nemaline rod myopathy

nemaline rod myopathy, adult onset

neonatal infection, viral

neoplasm, metastatic to CNS

neoplasm, primary intracerebral

nerve biopsy

nerve block

nerve conduction studies

nerve root enhancement

nerve root hypertrophy

neuralgia

neurofibrillary degeneration

neuroleptic

neurologic complications

neurologic complications of, surgery

neurologic complications of, systemic disease

neurologic disease

neurologic disease, diagnoses of

neurologic disease, tempo

neurologic examination, focal

neurologic history

neurologic signs

neurologic symptoms

neuromuscular blockade

neuronopathy

neuropathology

neuropathology, brain

neuropathy

neuropathy, acute

neuropathy, cryoglobulinemic

neuropathy, demyelinating

neuropathy, iatrogenic

neuropathy, medication induced

neuropathy, painful

neuropathy, peripheral

neuropathy, peripheral, treatment

neuropathy, sensory

neuropathy, toxic

neuropathy, vasculitic, nonsystemic

neurosyphilis

neurotoxic

neurotoxin

neutralizing antibodies

neutropenia

nicotine

nocardiosis

nonsteroidal anti-inflammatory drug

number needed to treat

nystagmus

old age, neurology of

Ommaya reservoir

opportunistic infection

opportunistic infection, CNS

optic atrophy

optic neuritis

optic neuropathy

optic neuropathy, ischemic

optic neuropathy, ischemic, posterior

organ transplantation

pain, management of chronic

paresthesias, circumoral

paresthesias, facial

paresthesias, feet

Parkinson disease

Parkinson disease, young onset

Parkinsonism syndrome

parotid gland swelling

patient information and support

penicillamine

peripheral blood stem cell transplantation

peripheral pulse, absent

pleocytosis of cerebrospinal fluid

pleurisy

pneumocystis carinii

polyinosinic cytidic acid(poly IC)

polymerase chain reaction

polymerase chain reaction, false negative

polymyositis

polyneuropathy

polyneuropathy, chronic inflammatory demyelinating

polyradiculoneuropathy

pons, lesion of

positive sharp waves

post herpetic neuralgia

posterior leukoencephalopathy syndrome

practice guidelines

precipitating factors

preexposure prophylaxis

pregnancy, neurologic complications in

preherpetic neuralgia

prevention of neurologic disorders

prognosis

progressive multifocal leucoencephalopathy

progressive multifocal leukoencephalopathy, etiology

progressive neurologic disorder

protease inhibitor, HIV-1

proximal muscle atrophy

pseudocyst

psoriatic arthritis

psychiatric problems in neurologic disorders

psychological testing

psychological testing, neurologic problems

psychomotor retardation

psychosis

pulmonary infiltrates

pyramidal tract dysfunction

pyramidal tract dysfunction, unilateral

radiation therapy, CNS treatment and complications with

radiation therapy, total body

remote effect of cancer on the nervous system

renal failure

renal failure, acute

renal stones

renal transplantation

research

respiratory failure

respiratory tract infection

reversible cerebral vasoconstrictive syndromes

salivary gland enlargement

saquinavir

sarcoidosis

screening

sedimentation rate, elevated

seizure

seizure, drug-induced

seizure, focal

seizure, intractable

seizure, neonatal

seizure, psychomotor-temporal lobe

seizure, treatment of

selective serotonin reuptake inhibitors

sensorineural hearing loss

sensory ganglia

seroconversion

serologic testing

serologic testing of cerebrospinal fluid

seronegative

serum alanine aminotransferase

serum glutamic oxaloacetic transaminase

sexually transmitted disease

sicca syndrome

single photon emission computed tomography

single photon emission computed tomography, thallium

skin, discoloration

skin, lesions in neurologic disorders

slow virus infection of CNS

small for dates infant, problems in

snout reflex

soap-bubble appearance

spinal cord, lesion of

splenectomy

statin therapy

status epilepticus

stem cell transplantation

steroid

steroid therapy, CNS treatment and complications with

striatal encephalitis

striatum, lesion of, bilateral

stroke center

stuporous

subacute myelo-opticoneuropathy(S.M.O.N.)complex

subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease

subacute sclerosing panencephalitis, adult onset

subdural hematoma

subdural hematoma, bilateral

subdural hematoma, posterior fossa

subtemporal decompression

sumatriptan

symmetric brain lesions

sympathetic block

syphilis, neurologic complications with

systemic illness

systemic lupus erythematosus

temporal artery, biopsy

temporal lobe, lesion

temporal lobe, lesion, bilateral

temporal lobectomy

term infant

tetrahydroaminoacridine

transcutaneous electrical nerve stimulation

transient ischemic attack

transplacental virus infections

travel history

treatment delay

treatment of neurologic disorder

treatment, empirical

tremor

tremor, intention

tricyclic antidepressant

trigeminal neuralgia

trigeminal neuralgia, surgical treatment of

tumor necrosis factor inhibitor

ultrasonography, head

varicella zoster virus

varicella zoster virus, encephalitis

varicella zoster virus, vasculopathy

ventricular enlargement

vincristine neurotoxicity

viral escape

viral infection

viral infection, CNS

viral infection, CNS, treatment of

viral isolation

viral load

Virchow-Robin spaces, dilated

visual impairment

visual loss

visual loss, sudden-unilateral

walking, delayed

walking, difficulty with

weakness

weakness, focal

weakness, generalized

weakness, progressive

web sites

weight loss

Wernicke's encephalopathy

West Nile fever

Western immunoblot test

white matter disease

white matter, dirty-appearing

wide based gait

word-finding difficulty

Showing articles 1250 to 1300 of 3506 << Previous Next >>

Safety of Biologic Agents After Rituximab Therapy in Patients With Rheumatoid Arthritis
Rheum Int: December 2009, Mishra, R.,et al, 2009

MRI Findings Associated With Acute Liver Failure
Neurol 72:2130-2131, Fridman,V.,et al, 2009

Oral Fingolimod (FTY720) in Multiple Sclerosis: Two-Year Results of a Phase II Extension Study
Neurol 72:73-79, OConnor,P.,et al, 2009

Use of MRI to Estimate the Therapeutic Window in Acute Stroke: Is Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch an EPITHET for Salvageable Ischemic Brain Tissue?
Stroke 40:333-335, Toth,G. &Albers,G.W., 2009

Cost-Effectiveness of Patient Selection Using Penumbral-Based MRI for Intravenous Thrombolysis
Stroke 40:1710-1720, Earnshaw,S.R.,et al, 2009

Identifying Patients at High Risk for Poor Outcomes After Intra-Arterial Therapy for Acute Ischemic Stroke
Stroke 40:1780-1785, Hallevi,H.,et al, 2009

Fast-In, Fast-Out
Lancet 373:1398, Hefele,B.,et al, 2009

Diagnostic Value of N-methyl-D-aspartate Receptor Antibodies in Women with New-Onset Epilepsy
Arch Neurol 66:458-464, Niehusmann,P.,et al, 2009

Treatment of CNS Sarcoidosis with Infliximab and Mycophenolate Mofetil
Neurol 72:337-340, Morovan,M. &Segal,B.M., 2009

Immunologic, Clinical, and Radiologic Status 14 Months After Cessation of Natalizumab Therapy
Neurol 72:396-401,392, Stuve,O.,et al, 2009

Assessment of Potential Drug Interactions in Patients with Epilepsy: Impact of Age and Sex
Neurol 72:419-425, Gidal,B.E.,et al, 2009

Posterior Reversible Encephalopathy Syndrome in Neuromyelitis Optica Spectrum Disorders
Neurol 72:712-717, Maga�a,S.M.,et al, 2009

Thrombolytic Therapy for Patients Who Wake-Up With Stroke
Stroke 40:827-832, Barreto,A.D.,et al, 2009

Thrombolysis in Childhood Stroke: Report of 2 Cases and Review of the Literature
Stroke 40:801-807, Arnold,M.,et al, 2009

Disappearing Hyperdense Middle Cerebral Artery Sign in Ischaemic Stroke Patients Treated with Intravenous Thrombolysis: Clinical Course and Prognostic Significance
JNNP 80:273-278,248, Kharitonova,T.,et al, 2009

Intravascular Lymphoma Masquerading as Multiembolic Stroke Developing After Coronary Artery By-Pass Surgery
The Neurologist 15:98-101, Sumer,M.,et al, 2009

Carbon Monoxide Poisoning
NEJM 360:1217-1225, Weaver,L.K., 2009

Multiple Sclerosis Therapeutics: Unexpected Outcomes Clouding Undisputed Successes
Neurol 72:1008-1015, Wiendl,H. &Hohlfeld,R., 2009

The Ethics of Thrombolytic Trials Beyond 3 (or 4.5) Hours: Randomized Controlled Trials Are Required to Change Clinical Practice
Stroke 40:1545, Donnan,G.A. &Davis,S.M., 2009

Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial by Stroke Subtypes
Stroke 40:1405-1409, Amarenco,P.,et al, 2009

Opportunistic Infections and Other Risks with Newer Multiple Sclerosis Therapies
Ann Neurol 65:367-377, Berger,J.R. &Houff,S., 2009

Angiotensin Receptor Blockers Should Be Regarded as First-Line Drugs for Stroke Prevention in Both Primary and Secondary Prevention Settings: No
Stroke 40:3161-3162, 3163, Strauss,M. &Hall,A., 2009

Angiotensin Receptor Blockers Should Be Regarded as First-Line Drugs for Stroke Prevention in Both Primary and Secondary Prevention Settings: Yes
Stroke 40:3159-3160, 3163, Hackam,D., 2009

Intracranial Atherosclerotic Disease: An Update
Ann Neurol 66:730-738, Qureshi,A.,et al, 2009

Evaluation and Treatment of Inflammatory Myopathies
JNNP 80:1060-1068, Amato,A. &Barohn,R.J., 2009

A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinsons Disease
NEJM 361:1268-1278, 1304, Olanow,C.,et al, 2009

Treatment of Neuromyelitis Optica with Mycophenolate Mofetil
Arch Neurol 66:1128-1133, Jacob,A.,et al, 2009

Progressive Multifocal Leukoencephalopathy After Natalizumab Monotherapy
NEJM 361:1081-1087, Linda,H.,et al, 2009

Asymptomatic Reactivation of JC Virus in Patients Treated with Natalizumab
NEJM 361:1067-1074, Chen,Y.,et al, 2009

Treatment of Progressive Multifocal Leukoencephalopathy Associated with Natalizumab
NEJM 361:1075-1080, Wenning,W.,et al, 2009

Brainstem Lesions in Diffusion Sequences of MRI Can be Reversible After Arterial Recanalization
Neurol 73:813-815, Vilas,D., 2009

Cyclophosphamide Therapy in Pediatric Multiple Sclerosis
Neurol 72:2076-2082,2064, Makhani,N.,et al, 2009

Primary Angiitis of the Central Nervous System
Arch Neurol 66:704-709, Birnbaum,J. &Hellmann,D.B., 2009

Anti-N-Methyl-D-Aspartate Receptor (NHMDAR) Encephalitis in Children and Adolescents
Ann Neurol 66:11-18,1, Florance,N.R.,et al, 2009

Transcranial Ultrasound in Clinical Sonothrombolysis (TUCSON) Trial
Ann Neurol 66:28-38, Molina,C.A.,et al, 2009

Statin Treatment and Stroke Outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial
Stroke 40:3526-3531,3413, Goldstein,L.,et al, 2009

Interventions in the Management of Serum Lipids for Preventing Stroke Recurrence
Stroke 40:e622-e623, Manktelow,B. &Potter,J., 2009

Point-of-Care International Normalized Ratio Testing Accelerates Thrombolysis in Patients With Acute Ischemic Stroke Using Oral Anticoagulants
Stroke 40:3547-3551, Rizos,T.,et al, 2009

Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab
Ann Neurol 66:403-406, 261, 262, Schweikert,A.,et al, 2009

Natalizumab and Central Nervous System Lymphoma: No Clear Association
Ann Neurol 66:261-262, Bozic,C.,et al, 2009

Natalizumab: A Double-Edged Sword?
Ann Neurol 66:262-263, DeAngelis,L., 2009

Intraventricular Fibrinolysis and Lumbar Drainage for Ventricular Hemorrhage
Stroke 40:3275-3280, Staykov,D.,et al, 2009

Toxic and Drug-Induced Myopathies
JNNP 80:832-838, Dalakas,M.C., 2009

Expansion of the Time Window for Treatment of Acute Ischemic Stroke with Intravenous Tissue Plasminogen Activator: A Science Advisory from the American Heart Association/American Stroke Association
Stroke 40:2945-2948, del Zoppo,G.J.,et al, 2009

MR Mismatch Is Useful for Patient Selection for Thrombolysis: Yes
Stroke 40:2906-2907,2910, Fiebach,J.B. &Schellinger,P.D., 2009

Hearing Improvement After Bevacizumab in Patients with Neurofibromatosis Type 2
NEJM 361:358-367, Plotkin,S.R.,et al, 2009

Frequency, Characteristics, and Risk Factors for Amiodarone Neurotoxicity
Arch Neurol 66:865-869, Orr,C.F. &Ahlskog,E., 2009

Intraarterial Thrombolysis Within the First Three Hours After Acute Ischemic Stroke in Selected Patients
Stroke 40:2611-2612,2615, Moonis,M., 2009

Is Intraarterial tPA Within 3 Hours the Treatment of Choice for Selected Stroke Patients? No
Stroke 40:2613-2614,2615, Lindley,R.I., 2009

Number Needed to Treat to Benefit and to Harm for Intravenous Tissue Plasminogen Activator Therapy in the 3- to 4.5-Hour Window: Joint Outcome Table Analysis of the ECASS 3 Trial
Stroke 40:2433-2437,2295, Saver,J.L.,et al, 2009

Showing articles 1250 to 1300 of 3506 << Previous Next >>